Cognition Therapeutics, Inc.CGTXNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-29.53M
↓ 100% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
$-14.75M
Historical baseline
PeriodValueYoY Change
TTM$-29.53M-3.7%
2024$-28.48M-76.2%
2023$-16.16M+13.6%
2022$-18.70M-411.3%
2021$-3.66M-6.2%
2020$-3.44M-6.2%
2019$-3.24M-